EUVIMEDEUVIMED entdecken
Crossref

Bempedoic acid for primary hypercholesterolaemia

Steve Chaplin

Prescriber · 2021-01 · 32 (1) · 29-31

DOI: 10.1002/psb.1888 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Prescriber, online erschienen am 21.01.2021. Verfasst von Steve Chaplin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bempedoic acid (Nilemdo) is a new lipid‐lowering therapy for the treatment of primary hypercholesterolaemia and mixed dyslipidaemia. This article summarises its mechanism of action, clinical trial efficacy and side‐effects.

Zitieren

APA

Chaplin, S. (2021). Bempedoic acid for primary hypercholesterolaemia. Prescriber, 32(1), 29-31. https://doi.org/10.1002/psb.1888

Vancouver

Chaplin S. Bempedoic acid for primary hypercholesterolaemia. Prescriber. 2021;32(1):29-31. doi:10.1002/psb.1888

BibTeX
@article{Chaplin2021,
  author = {Chaplin, Steve},
  title = {Bempedoic acid for primary hypercholesterolaemia},
  journal = {Prescriber},
  year = {2021},
  volume = {32},
  number = {1},
  pages = {29--31},
  doi = {10.1002/psb.1888}
}
Kostenlos starten →